Southeast Asia map

Addressing The Rapidly Growing Southeast Asia Bioprocessing Market

by

Excerpt Singapore has been receiving notable investments in facility set-up and expansion. Thailand is seeing increase in the demand for viral vector manufacturing and the production of plasmid DNA and fusion proteins. While the biotech industry is still in its infancy in countries like Indonesia and Vietnam, there has been emphasis on development of biotech […]

bioprocessing facilities article

APAC Bioprocessing Facilities Market Trends This 2021

by

Excerpt 36% of all bioprocessing facilities in the Asia Pacific are engaged in the manufacturing of novel monoclonal antibodies. More than 40% of the manufacturing facilities in APAC have progressed from establishment to operations within the past 2 years. Biopharmaceutical companies in APAC are inclined towards adopting more process innovation technologies while expanding their facilities. […]

Biosimilar producer looking to get first to market advantage in China and Europe

Biosimilar producer looking to get first to market advantage in China and Europe

by

Excerpt Bio-Thera Solutions, a biopharmaceutical company based in Guangzhou, China, has initiated the first Phase 3 study of a golimumab biosimilar in China and Eastern Europe, which is expected to enrol 598 subjects and achieve completion by October 2023. As the first golimumab biosimilar to gain approval in multiple countries, BAT2506 gives Bio-Thera Solutions early […]

Takeda’s Official Ground-Breaking on its First “Net Zero Carbon Emissions” Building in Singapore

Takeda’s Official Ground-Breaking on its First “Net Zero Carbon Emissions” Building in Singapore

Excerpt Takeda recently held a ground-breaking ceremony for its first ‘Net Zero Carbon Emission’ building in its global manufacturing and supply network in Woodlands, Singapore. The building will follow Singapore Green Mark Zero Energy certification scheme. It is a $14 million USD expansion of the Woodlands facility and a first-of-its kind in the biotechnology industry in […]

WuXi Biologics Received First Manufacturing License from Japan and Completed 12 Global Regulatory Inspections in 2021 Year to Date

WuXi Biologics Received First Manufacturing License from Japan and Completed 12 Global Regulatory Inspections in 2021 Year to Date

WuXi Biologics (2269.HK, WuXi Bio), a global company with leading open-access biologics technology platforms, offering end-to-end solutions for discovery, development and manufacturing, announced that it received the Manufacturing Licence from Japan’s Minister of Health, Labor and Welfare (MHLW) for its drug substance facility (MFG2) at Wuxi city, China. After 2 days of remote GMP inspection, […]

Vigil Neuroscience Completes $90 million Series B Financing to Advance a Pipeline of Microglia-targeted Medicines to Treat Rare and Common Neurodegenerative Diseases

by Kashmiira Nayar

Excerpt Vigil Neuroscience has secured $90 million in its Series B financing led by Vida Ventures with participation from new as well as existing investors. This will propel the advancement of Vigil’s proprietary microglia-focused medicine line-up for the treatment of neurodegenerative diseases. Development of the antibody, VGL101, and triggering receptor on myeloid cells 2 (TREM2) […]

AGC Biologics Announces New Multipurpose Facility at its Copenhagen, Denmark Site

by Kashmiira Nayar

AGC Biologics announced multipurpose facility in its Copenhagen, Denmark site to increase its capacity and space to accommodate new and existing clients’ needs. The new facility will include a manufacturing building comprised of four levels holding approximately 8,000 square meters distributed across manufacturing, quality control laboratories, technical and warehouse areas. In addition, there will be […]

bag